Business Context and Reporting Period
Company: Helen of Troy Limited
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: November 30, 2003 (Third Quarter of Fiscal 2004)
Business Overview: The company manufactures and markets personal care appliances, hair and skin care products, and accessories. Operations are divided into North American, International, and Tactica segments. The period includes the impact of the September 2003 acquisition of the Brut® brand from Unilever NV.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Nov 30, 2003 | Nine Months Ended Nov 30, 2003 |
|---|---|---|
| Net Sales | $179,200 | $401,482 |
| Gross Profit | $82,787 | $188,637 |
| Gross Margin % | 46.2% | 47.0% |
| Operating Income | $30,325 | $61,195 |
| Net Earnings | $25,062 | $53,004 |
| Diluted EPS | $0.78 | $1.71 |
| Cash and Equivalents (Nov 30, 2003) | $10,036 | N/A |
| Short-term Debt | $21,000 | N/A |
| Long-term Debt | $55,000 | N/A |
| Working Capital | $165,415 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 25.3% ($36.2M) for the quarter and 12.6% ($44.9M) for the nine months compared to the prior year. Growth was driven by the North American and International segments, offset by a decline in the Tactica segment.
- Acquisition Impact: The acquisition of the Brut® brand contributed $9.6M to quarterly sales and $25.3M to nine-month sales. The acquisition was funded partially by a new $50M revolving credit facility.
- Profitability: Operating income rose 45.3% for the quarter and 41.8% for the nine months. Gross margins improved due to favorable product mix, lower sourcing costs, and currency benefits.
- Segment Performance:
- North America: Sales up 30% (quarter) and 20% (nine months).
- International: Sales up 55% (quarter) and 72% (nine months), aided by currency strength.
- Tactica: Sales declined 27% (quarter) and 41% (nine months) due to reduced Epil-Stop sales and infomercial demand softness. The segment reported an operating loss of $1.4M for the quarter.
- Liquidity: Cash and cash equivalents decreased from $47.8M to $10.0M. This reduction was primarily due to the Brut® acquisition ($55.3M total cost), increased inventory and receivables to support sales growth, and share repurchases.
Guidance, Outlook, Risks, and Unusual Items
- Strategic Review of Tactica: Management announced an evaluation of strategic alternatives for its 55% interest in Tactica, including a potential sale or restructuring, to maximize shareholder value.
- Share Repurchases: The company repurchased 231,800 shares during the quarter at an average price of $22.55. An additional 87,200 shares were repurchased post-period (Dec 1 - Jan 12).
- Tax Contingencies:
- Hong Kong: The Inland Revenue Department assessed $6.8M in taxes for 1995-1997. If applied to all years through Nov 2003, the liability could reach $42.2M. The company has recorded a liability and holds tax reserve certificates valued at $3.3M.
- IRS: The IRS is auditing returns for 1997-1999 with proposed adjustments potentially totaling $7.5M. The company is contesting these.
- Unusual Items: The nine-month period included $2.6M of income from the settlement of litigation with The Schawbel Corporation.
- Forward-Looking Risks: Risks include reliance on specific trademarks (Revlon, Brut), foreign currency fluctuations, potential changes in U.S. tax legislation affecting the company's Bermuda structure, and integration risks from the Brut® acquisition.
Investor Verification Checklist
- Tactica Restructuring: Verify the status of the strategic review for the Tactica subsidiary and potential impact on future earnings.
- Tax Liability Resolution: Monitor the outcome of the Hong Kong IRD assessment and the IRS audit, as the potential liabilities ($42.2M and $7.5M respectively) are material.
- Brut® Integration: Assess the performance of the newly acquired Brut® brand and the final allocation of the $55.3M purchase price, particularly regarding indefinite-life intangibles.
- Liquidity Management: Review the company's ability to service its new $50M revolving credit facility and manage working capital given the significant drop in cash reserves.
- Stock-Based Compensation: Note that the company uses the intrinsic value method (APB 25); proforma EPS under SFAS 123 would be lower ($0.74 diluted vs. $0.78 reported for the quarter).